With a mention in the Sunday Express yesterday helping along, OKYO Pharma (OKYO), a biotechnology company announced that its drug candidate OK-101 which was developed to treat DED through its
With a mention in the Sunday Express yesterday helping along, OKYO Pharma (OKYO), a biotechnology company announced that its drug candidate OK-101 which was developed to treat DED through its